a 2022

Chromatographic modeling as a tool in optimizing reversed-phase separation methods

ŠMAK, Pavel, Jana GREGOROVÁ, Lenka KUBINYIOVÁ, Jan ŠTINGL, Ondřej PEŠ et. al.

Basic information

Original name

Chromatographic modeling as a tool in optimizing reversed-phase separation methods

Name in Czech

Modelování chromatografie jako nástroj při optimalizaci separace na reverzních fázích

Authors

ŠMAK, Pavel, Jana GREGOROVÁ, Lenka KUBINYIOVÁ, Jan ŠTINGL and Ondřej PEŠ

Edition

23. Ročník školy hmotnostní spektrometrie, 2022

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

10609 Biochemical research methods

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Organization unit

Faculty of Medicine

ISBN

978-80-88195-25-2

Keywords in English

chromatography; method optimization; reversed-phase chromatography
Změněno: 5/4/2023 14:03, Mgr. Tereza Miškechová

Abstract

V originále

Gradient elution can significantly enhance the separation in terms of the run time and peaks’ shape in HPLC. However, optimizing a gradient elution method can be a laborious process, especially if a larger number of compounds, significantly differing in the chromatographic behavior, needs to be separated. Multiple approaches are employed in order to obtain an ideal gradient composition over time – ranging from the “trial and error” methods to complex mathematical models. These models often rely on the Snyder’s equation and its modifications. In a typical setup, two or more separations are initially performed, and the results are fed to a software analysis tool, which tries to predict ideal conditions for the current system. Up to date available software tools for gradient run optimization lack either financial affordability or a feature-rich interface. A software tool developed in Python was developed, tested, and will be presented.

Links

MUNI/A/1090/2021, interní kód MU
Name: Příspěvek {bio}chemických metod při studiu molekulární podstaty vybraných patologických jevů a onemocnění
Investor: Masaryk University